Our proprietary Ostaguard™antibacterial surface treatment is the first of its kind to be granted U.S. Food and Drug Administration (FDA) De Novo classification. With an initial application in the field of orthopedic spinal implants, Ostaguard is a non-eluting coating that is applied during the manufacturing process prior to packaging and sterilization—and designed to actively kill bacteria that contaminate the surface of a medical device. Orthobond CEO David Nichols explains how Ostaguard effectively kills 99.99% of the bacteria that can come in contact with an implantable device, the benefits of this antibacterial surface technology, and why you should be an early adopter.